Sponsor content
848 result(s) found, displaying 231 to 240
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRASTUCIP trastuzumab 150 mg powder for injection vial.
-
Prescription medicine registrationActive ingredients: Tiotropium bromide monohydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA HYDROCORTISONE hydrocortisone (as sodium succinate) 100 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CORTI-H hydrocortisone (as sodium succinate) 100 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYDROCIP hydrocortisone (as sodium succinate) 100 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CORTICIP hydrocortisone (as sodium succinate) 100 mg powder for injection vial.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023